Acorn Financial Advisory Services Inc Regeneron Pharmaceuticals, Inc. Transaction History
Acorn Financial Advisory Services Inc
- $508 Million
- Q3 2024
A detailed history of Acorn Financial Advisory Services Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Acorn Financial Advisory Services Inc holds 1,602 shares of REGN stock, worth $1.21 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
1,602
Previous 1,603
0.06%
Holding current value
$1.21 Million
Previous $1.68 Million
-0.0%
% of portfolio
0.33%
Previous 0.35%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,529Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.05 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.39 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.67 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.71 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.25 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $81.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...